BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang T, Lin R, Wu H, Jiang X, Gao J. Mesenchymal stem cells: A living carrier for active tumor-targeted delivery. Adv Drug Deliv Rev 2022;185:114300. [PMID: 35447165 DOI: 10.1016/j.addr.2022.114300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Shen Y, Bae YH. Tumour extravasation of nanomedicine: The EPR and alternative pathways. Adv Drug Deliv Rev 2023;194:114707. [PMID: 36657644 DOI: 10.1016/j.addr.2023.114707] [Reference Citation Analysis]
2 Gemayel J, Chaker D, El Hachem G, Mhanna M, Salemeh R, Hanna C, Harb F, Ibrahim A, Chebly A, Khalil C. Mesenchymal stem cells-derived secretome and extracellular vesicles: perspective and challenges in cancer therapy and clinical applications. Clin Transl Oncol 2023. [PMID: 36808392 DOI: 10.1007/s12094-023-03115-7] [Reference Citation Analysis]
3 Han H, Jin W, Li X. Mesenchymal stem cells-based therapy in liver diseases. Mol Biomed 2022;3:23. [DOI: 10.1186/s43556-022-00088-x] [Reference Citation Analysis]
4 Zhang J, Zhang T, Gao J. Biocompatible Iron Oxide Nanoparticles for Targeted Cancer Gene Therapy: A Review. Nanomaterials 2022;12:3323. [DOI: 10.3390/nano12193323] [Reference Citation Analysis]